These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 2258360)
1. Combined utility of gene rearrangement analysis and flow cytometry in the diagnosis of lymphoproliferative disease in the bone marrow. Sandhaus LM; Voelkerding KV; Dougherty J; Raska K Hematol Pathol; 1990; 4(3):135-48. PubMed ID: 2258360 [TBL] [Abstract][Full Text] [Related]
2. Bone marrow trephines containing lymphoid aggregates from patients with rheumatoid and other autoimmune disorders frequently show clonal B-cell infiltrates. Engels K; Oeschger S; Hansmann ML; Hillebrand M; Kriener S Hum Pathol; 2007 Sep; 38(9):1402-11. PubMed ID: 17560629 [TBL] [Abstract][Full Text] [Related]
3. Diagnosis of lymphoproliferative disorders: experience of a single institution in the long-term follow-up of discordant cases. Sadek I; Greer W; Foyle A Clin Invest Med; 2000 Dec; 23(6):366-75. PubMed ID: 11152404 [TBL] [Abstract][Full Text] [Related]
4. Bone marrow staging of patients with non-Hodgkin lymphoma by flow cytometry: correlation with morphology. Duggan PR; Easton D; Luider J; Auer IA Cancer; 2000 Feb; 88(4):894-9. PubMed ID: 10679660 [TBL] [Abstract][Full Text] [Related]
5. Leukemic phase of mantle cell lymphoma presenting as anemia: diagnosis by combining flow cytometry and cytomorphology. Brink DS; Grosso LE; Dunphy CH Arch Pathol Lab Med; 1998 Nov; 122(11):1018-22. PubMed ID: 9822132 [TBL] [Abstract][Full Text] [Related]
6. Follicular pattern of bone marrow involvement by follicular lymphoma. Torlakovic E; Torlakovic G; Brunning RD Am J Clin Pathol; 2002 Nov; 118(5):780-6. PubMed ID: 12428800 [TBL] [Abstract][Full Text] [Related]
7. Flow cytometry in the bone marrow staging of mature B-cell neoplasms. Stacchini A; Demurtas A; Godio L; Martini G; Antinoro V; Palestro G Cytometry B Clin Cytom; 2003 Jul; 54(1):10-8. PubMed ID: 12827663 [TBL] [Abstract][Full Text] [Related]
8. [The value of multiparameter flow cytometry in diagnosis of lymphocytic leukemia and bone marrow involvement of non-Hodgkin's lymphoma]. Sun XF; He LR; Feng HL; Yan SL; Xia ZJ; Chen XQ Ai Zheng; 2003 Nov; 22(11):1232-6. PubMed ID: 14613660 [TBL] [Abstract][Full Text] [Related]
9. Specificity of PCR-based clonality analysis of immunoglobulin heavy chain gene rearrangements for the detection of bone marrow involvement by low-grade B-cell lymphomas. Brinckmann R; Kaufmann O; Reinartz B; Dietel M J Pathol; 2000 Jan; 190(1):55-60. PubMed ID: 10640992 [TBL] [Abstract][Full Text] [Related]
10. Contribution of flow cytometric immunophenotyping and bone marrow trephine biopsy in the detection of lymphoid bone marrow infiltration in non-Hodgkin's lymphomas. Mazur G; Hałoń A; Wróbel T; Jeleń M; Kuliczkowski K Neoplasma; 2004; 51(3):159-63. PubMed ID: 15254666 [TBL] [Abstract][Full Text] [Related]
11. Detection of bone marrow minimal disease in non-Hodgkin's lymphoma patients by gene rearrangement analysis. Bregni M; Borrello MG; Siena S; Orazi A; Biassoni D; Bonadonna G; Gianni AM Haematologica; 1989; 74(4):397-400. PubMed ID: 2507414 [TBL] [Abstract][Full Text] [Related]
12. Morphologic, flow cytometric and cytogenetic evaluation of bone marrow involvement in B-cell lymphoma. Gomyo H; Shimoyama M; Minagawa K; Yakushijin K; Urahama N; Okamura A; Yamamoto K; Ito M; Chihara K; Hayashi Y; Matsui T Haematologica; 2003 Dec; 88(12):1358-65. PubMed ID: 14687988 [TBL] [Abstract][Full Text] [Related]
13. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases]. Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665 [TBL] [Abstract][Full Text] [Related]
14. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy? Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V; Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786 [TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic and immunogenotypic approaches useful in distinguishing benign and malignant lymphoid proliferations. Knowles DM Semin Oncol; 1993 Dec; 20(6):583-610. PubMed ID: 8296197 [TBL] [Abstract][Full Text] [Related]
16. Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas. Palacio C; Acebedo G; Navarrete M; Ruiz-Marcellán C; Sanchez C; Blanco A; López A Haematologica; 2001 Sep; 86(9):934-40. PubMed ID: 11532621 [TBL] [Abstract][Full Text] [Related]
17. Expression of bcl-2 protein in distinguishing benign from malignant lymphoid aggregates in bone marrow biopsies. Fakan F; Skálová A; Kuntscherová J Gen Diagn Pathol; 1996 May; 141(5-6):359-63. PubMed ID: 8780936 [TBL] [Abstract][Full Text] [Related]
18. Role of immunoglobulin heavy and light chain gene rearrangement analysis in differentiating between benign and malignant bone marrow B-cell lymphoid aggregates. Evans MG; Brynes RK; Crymes A; Reid J; Haghighi N; Botros C; Zhao X; Rezk SA Hum Pathol; 2022 Dec; 130():58-64. PubMed ID: 36252861 [TBL] [Abstract][Full Text] [Related]
19. Three-dimensional reconstruction of non-Hodgkin's lymphoma in bone marrow trephines. Salisbury JR; Deverell MH; Seaton JM; Cookson MJ J Pathol; 1997 Apr; 181(4):451-4. PubMed ID: 9196445 [TBL] [Abstract][Full Text] [Related]
20. Polymerase chain reaction-based diagnosis of bone marrow involvement in 170 cases of non-Hodgkin lymphoma. Kang YH; Park CJ; Seo EJ; Huh J; Kim SB; Kang YK; Chi HS Cancer; 2002 Jun; 94(12):3073-82. PubMed ID: 12115337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]